transCampus Team, 
A panel of experts, high-profile speakers and excellent young scientists came together in occasion of the joint meeting of the 5th Annual meeting of the International Research Training Group 2251 and the 2nd International Roadshow New Therapeutic Strategies in Apheresis, Cell and Gene Therapy in Diabetes and Metabolic Disease. The event that took place from 13 to 15 September in Dresden created an ideal platform to address various challenges and share their expertise.
After the opening by Professor Richard Trembath, Senior Vice President (Health & Life Sciences) of King’s College London and Executive Director of King’s Health Partners, and Professor Stefan Bornstein, the first day of the congress was all about new therapeutic strategies, and numerous members from industry and start-ups, clinic and research presented the newest developments in these topics.
The agenda of the following two days focused on IRTG2251 projects and especially on the student’s projects and their scientific career. Their presentation and the following discussions showed the students’ excellent research progress that benefits from the cooperation, incentivized new project ideas of the new student cohort and strengthened the scientific ties between the two partner institutes Dresden and London.
The annual IRTG2251 retreats are substantial for the progress and success of the student’s research as it creates the ideal platform to get in touch with the respective partner institutes, but also members from industry and start-ups, and to hold strategic discussions. As another highlight of the meeting, it was a special honor to welcome the Prof. Nadey Hakim (London), Prof. Julio Lucinio (New York) and Prof. Maha Saber-Ayad (Sharjah) as invited speakers to the congress. These experts-in-their’s-fields were sharing inspiring lectures and their latest research data with the audience, followed by lively and enthusiastic discussions.
Picture credits: Matthias Popp, UKD
